Frontlight ResearchEarly access
TerminatedNo phase
An Automated Continual Water Removal System in Patients With Advanced Diuretic Resistant Heart Failure
Key facts
- Who runs it
- Paragate Medical LTD
- Where
- Georgia, Israel, and Poland3 sites in 3 countriesChoose a country to see its sites
- Trial code
- Status
- Terminated
- People taking part
- 3 people enrolled
- Started
- 24 Feb 2022
- Ended
- 17 Jan 2024
- Type of study
- Interventional
- Treatments tested
- automated continual water removal system
- Record updated
- 19 January 2024
- Why it stopped
- challenges in recruitment
Who can take part
- Age
- 21 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- ≥ 21 years of age; Life expectancy > 6 months; HF, NYHA class II-IV; > 1 HF related admissions in the last 12 months; Fluid congestion (2 signs of pitting oedema, jugular distention, BW elevation, nocturnal dyspnoea score, respiration rate, pulmonary congestion and/or pleural effusion per chest x-ray, ascites); Failure to achieve effective diuresis and congestion relief despite appropriate or escalating diuretic doses or combination of diuretics (eg. Furosemide and Metolazone); Eligible for general anaesthesia and laparoscopic procedure; Able to give written informed consent; Ability to comply with study procedures and ability to operate the device; Women of childbearing potential should use adequate contraception for as long as the device is implanted
Who cannot take part
- • Any non-cardiac disease with life expectancy < 1 year; Any patient listed for solid organ transplantation; Patients with history, or with indication for, mechanical circulatory support; iv inotropes required in last 3 months (INTERMACS Score ≤3); Immunocompromised (e.g. chronic steroid treatment, HIV, etc.); Insulin dependent diabetes; Severe hyponatraemia as defined by a serum Sodium < 120 mmol/l; Serum Albumin < 2.5 g/dL; eGFR < 25 ml/min/1.73m2 by MDRD method; Previous significant intraabdominal surgery, severe abdominal adhesions, intra-abdominal foreign body (except for small inguinal mesh); Large diaphragmatic hernia, or surgically irreparable, complex or recurring hernia; 6 minutes' walk test of less than 100 meter; History (>6 months) of diaphragmatic hernia, inflammatory or ischemic bowel disease and frequent episodes of diverticulitis; Gastrointestinal haemorrhage within the last 4 months; Bacterial peritonitis episode within the last 24 months; > 2 systemic or local infections, such as urinary tract infection or abdominal skin infection within the last 6 months; Liver cirrhosis; BMI > 40 presenting a risk for surgery; Patients with contraindications for general anaesthesia or laparoscopic surgery; Unsuitability for self-maintenance of the experimental home set-up; Presence of any current cancer; Presence of any active implantable or body-worn devices that cannot be removed excluding ICD / pacemaker; Pregnancy; Patients being in another therapeutic clinical study
This trial has no sites in United States.
It has sites in 3 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study will assess the functionality and tolerability of an automated continual water removal system in up to 8 patients with HF and diuretic resistance.
Read full original descriptionShow less
intervention: Implanted absorption chamber, connected to an external pump. Follow up: 3 months post activation.
The group in the trial
- Implanted deviceTreatment being tested
Implantation and activation of an automated continual water removal system, including 4-months follow up
Treatment: automated continual water removal system
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- A Multi-centre, Prospective, Open Label, Uncontrolled Pilot Study to Assess the Feasibility and Tolerability of an Automated Continual Water Removal System in Patients With Advanced Diuretic Resistant Heart Failure
- Record updated
- 19 January 2024